AU2002325109C1 - Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments - Google Patents

Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments Download PDF

Info

Publication number
AU2002325109C1
AU2002325109C1 AU2002325109A AU2002325109A AU2002325109C1 AU 2002325109 C1 AU2002325109 C1 AU 2002325109C1 AU 2002325109 A AU2002325109 A AU 2002325109A AU 2002325109 A AU2002325109 A AU 2002325109A AU 2002325109 C1 AU2002325109 C1 AU 2002325109C1
Authority
AU
Australia
Prior art keywords
polypeptide
seq
moraxella
amino acid
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002325109A
Other languages
English (en)
Other versions
AU2002325109B2 (en
AU2002325109A1 (en
Inventor
Bernard R Brodeur
Julie Couture
Josee Hamel
Denis Martin
Stephane Rioux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Quebec
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Publication of AU2002325109A1 publication Critical patent/AU2002325109A1/en
Assigned to ID BIOMEDICAL CORPORATION reassignment ID BIOMEDICAL CORPORATION Request for Assignment Assignors: SHIRE BIOCHEM INC.
Publication of AU2002325109B2 publication Critical patent/AU2002325109B2/en
Application granted granted Critical
Publication of AU2002325109C1 publication Critical patent/AU2002325109C1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002325109A 2001-08-27 2002-08-27 Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments Ceased AU2002325109C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31463401P 2001-08-27 2001-08-27
US60/314,634 2001-08-27
PCT/CA2002/001315 WO2003018052A1 (en) 2001-08-27 2002-08-27 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments

Publications (3)

Publication Number Publication Date
AU2002325109A1 AU2002325109A1 (en) 2003-06-05
AU2002325109B2 AU2002325109B2 (en) 2008-04-10
AU2002325109C1 true AU2002325109C1 (en) 2009-04-02

Family

ID=23220768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002325109A Ceased AU2002325109C1 (en) 2001-08-27 2002-08-27 Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments

Country Status (7)

Country Link
US (1) US7329500B2 (https=)
EP (1) EP1420817A1 (https=)
JP (2) JP4397233B2 (https=)
CN (1) CN1549727A (https=)
AU (1) AU2002325109C1 (https=)
CA (1) CA2457779A1 (https=)
WO (1) WO2003018052A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1149164A2 (en) 1999-01-22 2001-10-31 SmithKline Beecham Biologics SA Neisseria meningitidis polypeptides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078968A2 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9817824D0 (en) 1998-08-14 1998-10-14 Smithkline Beecham Biolog Novel compounds
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
GB9921691D0 (en) 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078968A2 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Also Published As

Publication number Publication date
CN1549727A (zh) 2004-11-24
AU2002325109B2 (en) 2008-04-10
CA2457779A1 (en) 2003-03-06
US7329500B2 (en) 2008-02-12
WO2003018052A1 (en) 2003-03-06
JP4397233B2 (ja) 2010-01-13
JP2009279003A (ja) 2009-12-03
EP1420817A1 (en) 2004-05-26
JP2005507653A (ja) 2005-03-24
US20040242859A1 (en) 2004-12-02
WO2003018052A8 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
US7883706B2 (en) Methods for using Streptococcus pyogenes polypeptides
US20090074807A1 (en) Moraxella (branhamella) catarrhalis antigens
AU2002216863B8 (en) Streptococcus pyogenes antigens and corresponding DNA fragments
AU2002325109C1 (en) Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
US7410648B2 (en) Polypeptides of Moraxella (Branhamella) catarrhalis
EP1399563B1 (en) Moraxella (branhamella) catarrhalis antigens
AU2002302236A1 (en) Moraxella(Branhamella) catarrhalis antigens
AU2002325109A1 (en) Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
WO2004007725A9 (en) Polypeptide of streptococcus pyogenes
AU2002344869A1 (en) Moraxella (branhamella) catarrhalis antigens
JP2005514011A6 (ja) モラクセラ（ブランハメラ）カタルハリスのポリペプチド
WO2002079475A2 (en) Streptococcus pyogenes antigens and corresponding dna fragments
WO2004018514A1 (en) Polypeptides of nontypeable haemophilus influenzae and corresponding dna fragments

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ID BIOMEDICAL CORPORATION

Free format text: FORMER APPLICANT(S): SHIRE BIOCHEM INC.

FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 01 OCT 2008.

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 01 OCT 2008

MK14 Patent ceased section 143(a) (annual fees not paid) or expired